Comparing the hippocampal volumetric atrophy between demented and nondemented individuals with Parkinson's disease: A systematic review and meta-analysis
- PMID: 37701357
- PMCID: PMC10494130
- DOI: 10.1002/hsr2.1514
Comparing the hippocampal volumetric atrophy between demented and nondemented individuals with Parkinson's disease: A systematic review and meta-analysis
Abstract
Background: Parkinson's disease (PD) is one of the most common neurodegenerative conditions in the world and, when combined with dementia, can lead to immense cerebral volume loss. Of significant importance among all cerebral regions, is the hippocampus. This region plays a pivotal role in memory, and understanding its pathological alterations can answer vital questions regarding dementia. As such, we designed this study to compare the hippocampal volumes of PD patients with dementia (PDD) versus PD without dementia.
Methods: PubMed, Web of Science, Scopus, and Embase were searched for relevant studies. We also searched the references sections of all included studies. The original search began in March 2022 and was extended to the end of July 2022. All related data were extracted from the studies. If the studies were conducted on patients from comparable patient groups, the most recent study with the most extensive data set would be included.
Results: A statistically significant difference was observed comparing the raw hippocampal volumes in participants with PDD and PD (p value = 0.01). In a comparison of normalized hippocampal volume between PDD and PD, there was a statistically significant difference (p value < 0.01), as well.
Conclusion: Although further research is required to illuminate the temporal relation between the onset of dementia and hippocampal atrophy in demented PD individuals, the present study highlights the importance of utilizing volumetric studies on memory-related cerebral regions to diagnose the initiation of dementia in the early stages.
Keywords: Parkinson's disease; dementia; hippocampal atrophy; volumetry.
© 2023 The Authors. Health Science Reports published by Wiley Periodicals LLC.
Conflict of interest statement
The authors declare no conflict of interest.
Figures





Similar articles
-
Hippocampal subfield atrophy of CA1 and subicular structures predict progression to dementia in idiopathic Parkinson's disease.J Neurol Neurosurg Psychiatry. 2019 Jun;90(6):681-687. doi: 10.1136/jnnp-2018-319592. Epub 2019 Jan 25. J Neurol Neurosurg Psychiatry. 2019. PMID: 30683708
-
Parkinson's disease is associated with hippocampal atrophy.Mov Disord. 2003 Jul;18(7):784-90. doi: 10.1002/mds.10444. Mov Disord. 2003. PMID: 12815657
-
Amygdalar and hippocampal MRI volumetric reductions in Parkinson's disease with dementia.Mov Disord. 2005 May;20(5):540-4. doi: 10.1002/mds.20371. Mov Disord. 2005. PMID: 15645532
-
Cognitive training interventions for dementia and mild cognitive impairment in Parkinson's disease.Cochrane Database Syst Rev. 2020 Feb 26;2(2):CD011961. doi: 10.1002/14651858.CD011961.pub2. Cochrane Database Syst Rev. 2020. PMID: 32101639 Free PMC article.
-
Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer's disease in people with mild cognitive impairment.Cochrane Database Syst Rev. 2020 Mar 2;3(3):CD009628. doi: 10.1002/14651858.CD009628.pub2. Cochrane Database Syst Rev. 2020. PMID: 32119112 Free PMC article.
Cited by
-
Pathobiology of Cognitive Impairment in Parkinson Disease: Challenges and Outlooks.Int J Mol Sci. 2023 Dec 29;25(1):498. doi: 10.3390/ijms25010498. Int J Mol Sci. 2023. PMID: 38203667 Free PMC article. Review.
-
Hippocampal subfields: volume, neuropathological vulnerability and cognitive decline in Alzheimer's and Parkinson's disease.Alzheimers Res Ther. 2025 May 30;17(1):121. doi: 10.1186/s13195-025-01768-w. Alzheimers Res Ther. 2025. PMID: 40448161 Free PMC article.
References
-
- Bloem BR, Okun MS, Klein C. Parkinson's disease. Lancet. 2021;397(10291):2284‐2303. - PubMed
-
- Severiano e Sousa C, Alarcão J, Pavão Martins I, Ferreira JJ. Frequency of dementia in Parkinson's disease: a systematic review and meta‐analysis. J Neurol Sci. 2022;432:120077. - PubMed
-
- De Rui M, Inelmen EM, Trevisan C, Pigozzo S, Manzato E, Sergi G. Parkinson's disease and the non‐motor symptoms: hyposmia, weight loss, osteosarcopenia. Aging Clin Exp Res. 2020;32(7):1211‐1218. - PubMed
-
- Delgado‐Alvarado M, Gago B, Navalpotro‐Gomez I, Jiménez‐Urbieta H, Rodriguez‐Oroz MC. Biomarkers for dementia and mild cognitive impairment in Parkinson's disease. Mov Disorders. 2016;31(6):861‐881. - PubMed
-
- Wallace ER, Segerstrom SC, van Horne CG, Schmitt FA, Koehl LM. Meta‐analysis of cognition in Parkinson's disease mild cognitive impairment and dementia progression. Neuropsychol Rev. 2022;32(1):149‐160. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials